Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies

Cancer and Metastasis Reviews

Volumn 20, Issue 1-2, 2001, Pages 43-50

  Hazlehurst, Lori A ^a,b   Dalton, William S ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Betal integrins; CAM DR; Drug resistance; p27kip1; Topoisomerase II

Indexed keywords

CELL ADHESION MOLECULE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; GYRASE INHIBITOR; INTEGRIN; PROTEIN P27;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL ADHESION; CELL INTERACTION; CYTOSKELETON; DNA DAMAGE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DRUG RESISTANCE, NEOPLASM; FIBRONECTINS; HUMANS; MULTIPLE MYELOMA; TUMOR SUPPRESSOR PROTEINS;

EID: 0035692411     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013156407224     Document Type: Article

References (55)

1. Effects of intercellular contact on repair of radiation damage
2. Multicell spheroids as a model for cell kinetic studies
3. Drug and radiation resistance in spheroids: Cell contact and kinetics
4. Kip1 on resistance of tumor cells to anticancer agents
5. p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells
6. P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo
7. Cell fusion studies to examine the mechanism for etoposide resistance in chinese hamster V79 spheroids
8. Changes in subcellular distribution of topoisomerase II alpha correlate with etoposide resistance in multicell spheroids and xenograft tumors
9. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors
10. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
11. p27 is involved in N-cadehrin-mediated contact inhibition of cell growth and S-phase entry
12. Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1
13. p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma
14. Adhesion to fibronectin regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)
15. Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors
16. p27Kip1, a cyclin-CDK inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
17. Activation of β1 integrin fibronectin receptors on HL60 cells after granulocytic differentiation
18. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow
19. Bone marrow matrix promotes differentiation and prolongs the cell cycle of U-937 cells
20. Rescue from apoptosis in early (CD34-selected) versus late (non CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells
21. Signaling by integrin receptors
22. Cell adhesion molecules: Selectins and integrins
23. Alternatively spliced variants: A new view of the integrin cytoplasmic domain
24. The role of phosphorylation in modulating beta 1 integrin localization
25. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase
26. Mapping in vivo associations of cytoplasmic proteins with integrin beta 1 cytoplasmic domain mutants
27. Disruption of epithelial cell-matrix interactions induces apoptosis
28. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle
29. Integrins and anoikis
30. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
31. Integrin-mediated drug resistance in multiple myeloma
32. Cell adhesion mediated resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition cyctoxic drugs and γ radiation
33. Reduction in drug-induced DNA double strand-breaks associated with β1 integrin-mediated adhesion correlates with drug resistance in U937 cells
34. Bcr-Abl exerts its anti-apoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3
35. Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells
36. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
37. Effects of the bcr/abl kinase inhibitors AG957 and NSC680410 on chronic myelogenous leukemia cells in vitro
38. Adriamycin-induced DNA damage mediated by mammalian DNA topoiosmerase II
39. Cleavage of DNA by mammalian topoisomerase II
40. Integrin activation supresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells
41. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
42. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin
43. Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo
44. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell spreading on fibronectin
45. Integrin-mediated activation of MAP kinase is independent of FAK: Evidence for dual integrin signaling pathways in fibroblasts
46. A beta 1 integrin signaling pathway involving Src-family kinases, Cb1 and PI-3 kinase is required for macrophage spreading and migration
47. Alpha 5 beta 1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway
48. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and RAF-1/mitogen-activated protein kinase pathway activation
49. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation
50. Monoclonal antibody crosslinking of the α4 or β1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation
51. Activation-dependent α5β1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells
52. c integrin in prostatic adenocarcinoma
53. 1c
54. 1D integrin inhibits cell cycle progression in normal myoblasts and fibroblasts
55. The role of adhesion molecules in multiple myeloma